New Frontier Group acquires Hong Kong Integrated Oncology Centre

Overview

New Frontier Group has completed the acquisition of Hong Kong Integrated Oncology Center (HKIOC), a leading comprehensive private oncology medical platform.

Post Acquisition Impacts

• Through this acquisition, New Frontier will own HKIOC’s operations, including HKIOC Centre (Hong Kong Island), HKIOC Centre (Kowloon), and Hong Kong Adventist Hospital Oncology Center. 
• HKIOC provides a full range of cancer treatment services, including early diagnosis, radiotherapy, systemic treatments, mental health, and other rehabilitation support services.

HKIOC Coolab with HEAL Oncology

• HKIOC will join forces with New Frontier’s subsidiary, HEAL Oncology, to become one of Hong Kong’s leading private comprehensive oncology entities. 
• HKIOC and HEAL Oncology, and United Family Healthcare, also a subsidiary of New Frontier, will work together to elevate cross-border cancer care. 
• Through this partnership, surgeons, oncologists, and other allied health specialists will create a nationwide multidisciplinary cancer network.

This is one of Hong Kong’s most significant healthcare-related acquisitions in recent years. It not only extends New Frontier’s presence in the Greater Bay Area, but also provides a catalyst for the development of cancer care in the region. This acquisition is underpinned by New Frontier’s strong conviction in the supply and demand mismatch of the cancer population.

Team for the Personalised Treatment Plan

• This acquisition has unlocked deep sub-specialisations across different cancer types. 
• In addition, multidisciplinary team comprising of surgeons, oncologists, radiologists, pathologists, radiation therapists, pharmacists, etc., will work together to formulate a precise and personalised treatment plan.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!